Evelo Biosciences Target of Unusually High Options Trading

EVLODelisted Stock  USD 8.23  2.68  24.56%   
About 61% of Evelo Biosciences' investor base is looking to short. The analysis of overall sentiment of trading Evelo Biosciences pink sheet suggests that many investors are alarmed at this time. Evelo Biosciences' investing sentiment overview a quick insight into current market opportunities from investing in Evelo Biosciences. Many technical investors use Evelo Biosciences stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
  
Evelo Biosciences, Inc. was the recipient of unusually large options trading activity on Wednesday. Traders acquired 1,885 put options on the stock. This is an increase of 1,101 percent compared to the average volume of 157 put options. Evelo Biosciences Stock Up 9.9 percent Shares of NASDAQ EVLO opened at 6.24

Read at thelincolnianonline.com
news
  

Evelo Biosciences Fundamental Analysis

We analyze Evelo Biosciences' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Evelo Biosciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Evelo Biosciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Price To Book

Price To Book Comparative Analysis

Evelo Biosciences is currently under evaluation in price to book category among its peers. Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.

Evelo Biosciences Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Evelo Biosciences pink sheet to make a market-neutral strategy. Peer analysis of Evelo Biosciences could also be used in its relative valuation, which is a method of valuing Evelo Biosciences by comparing valuation metrics with similar companies.

Peers

Evelo Biosciences Related Equities

ENSCEnsysce Biosciences   14.58   
0%
100.0%
WINTWindtree Therapeutics   12.00   
0%
82.0%
CTMXCytomX Therapeutics   6.25   
0%
42.0%
PCSAProcessa Pharmaceuticals   4.08   
0%
27.0%
ALRNAileron Therapeutics   4.07   
0%
27.0%
NUVBNuvation Bio   3.21   
0%
22.0%
SRZNSurrozen   3.19   
0%
21.0%
GBIOGeneration Bio   2.86   
0%
19.0%
ASMBAssembly Biosciences   2.63   
0%
18.0%
TPSTTempest Therapeutics   2.17   
0%
14.0%
ERASErasca   0.72   
0%
4.0%
EWTXEdgewise Therapeutics   0.31   
0%
2.0%
ABVCABVC Biopharma   1.92   
13.0%
0%
KRONKronos Bio   2.25   
15.0%
0%
TILInstil Bio   2.83   
19.0%
0%
CCCCC4 Therapeutics   4.34   
29.0%
0%
DRMADermata Therapeutics   4.35   
29.0%
0%
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.

Other Consideration for investing in Evelo Pink Sheet

If you are still planning to invest in Evelo Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Evelo Biosciences' history and understand the potential risks before investing.
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities